Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Viking49on Jul 18, 2019 10:35pm
160 Views
Post# 29937823

RE:RE:RE:$2.36.

RE:RE:RE:$2.36.
MUTHATRUCKA wrote: Most of these are overvalued. Canopy growth can't be worth more than eighteen bucks per share. But don't mention that to anybody or they'll freak. My long plays right now are with some of these smaller penny stocks in the Cannabis sector. BE may only be hanging around the $0.08 mark, but at least it's closer to its real value. Over the next few years it's going to be the people that can actually grow good weed who are going to make the real gains.... I wish they would legalize hash. Now there's a real Market. Anyone here old enough to remember Lebanese blonde hash? Makes my eyes red just thinking about it.


Hash will be allowed when HC expands the product offerings this fall.

I liked the black Afghan with opium streaks.  Mellow!


Bullboard Posts